Norder Helene, Bjerregaard Lotte, Magnius Lars, Lina Bruno, Aymard Michèle, Chomel Jean-Jacques
Swedish Institute for Infectious Disease Control, S-171 82 Solna, Sweden.
Centre National de Reference des Enterovirus, Lyon, France.
J Gen Virol. 2003 Apr;84(Pt 4):827-836. doi: 10.1099/vir.0.18647-0.
The N-terminal part of VP1 was sequenced for 43 enterovirus isolates that could not initially be neutralized with LBM pools or in-house antisera. Most isolates were found to belong to human enterovirus type A (HEV-A) and HEV-B (18 isolates of each). All HEV-A isolates could be typed by sequencing, with CV (coxsackievirus)-A16 and EV (enterovirus)-71 being dominant (nine and seven isolates, respectively). These types thus seem to have diverged more from their prototypes than the other types. Among the HEV-B isolates, E-18 dominated with five isolates that became typable after filtration. The virus type obtained by molecular typing was verified for 28 of the other patient isolates by neutralization using high-titre monovalent antisera or LBM pools. Twenty-two of the other 30 'untypable' isolates had substitutions in the VP1 protein within or close to the BC loop. Two closely related HEV-B isolates diverged by 19.4 % from E-15, the most similar prototype. Two non-neutralizable HEV-C isolates split off from the CV-A13/CV-A18 branch, from which they diverged by 15.7-18.2 %. Three of the six non-neutralizable isolates, W553-130/99, W543-122/99 and W137-126/99, diverged by >24.2 % from the most similar prototype in the compared region. The complete VP1 was therefore sequenced and found to diverge by >29 % from all prototypes and by >28 % from each other. Strains similar to W553-130/99 that have been identified in the USA are tentatively designated EV-74. The two other isolates fulfil the molecular criterion for being new types. Since strains designated EV-75 and EV-76 have been identified in the USA, we have proposed the tentative designations EV-77 and EV-78 for these two new members of HEV-B.
对43株最初不能被LBM混合血清或内部抗血清中和的肠道病毒分离株的VP1蛋白N端进行了测序。大多数分离株被发现属于人肠道病毒A组(HEV - A)和B组(HEV - B)(每组各18株)。所有HEV - A分离株均可通过测序分型,其中柯萨奇病毒A16型(CV - A16)和肠道病毒71型(EV - 71)占主导(分别为9株和7株)。因此,与其他类型相比,这些类型似乎与其原型的差异更大。在HEV - B分离株中,E - 18型占主导,有5株在过滤后可分型。通过使用高滴度单价抗血清或LBM混合血清进行中和试验,对另外28例患者分离株通过分子分型获得的病毒类型进行了验证。其他30株“无法分型”的分离株中有22株在VP1蛋白的BC环内或附近存在替换。两株密切相关的HEV - B分离株与最相似的原型E - 15相差19.4%。两株不可中和的HEV - C分离株从CV - A13/CV - A18分支分离出来,与该分支相差15.7% - 18.2%。6株不可中和的分离株中的3株,即W553 - 130/99、W543 - 122/99和W137 - 126/99,在比较区域与最相似的原型相差>24.2%。因此,对完整的VP1进行了测序,发现其与所有原型相差>29%,彼此之间相差>28%。在美国已鉴定出与W553 - 130/99相似的毒株,暂定为EV - 74。另外两株分离株符合新型别的分子标准。由于在美国已鉴定出命名为EV - 75和EV - 76的毒株,我们对HEV - B的这两个新成员提出了暂定命名为EV - 77和EV - 78。